Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04811014 · ClinicalTrials.gov registry record · Phase 4

Young Houston Emergency Opioid Engagement System

A Phase 4 study of Opioid Use Disorder and Opioid Use, sponsored by The University of Texas Health Science Center, Houston.

Recruiting
Registry status
Phase 4
Development phase
250
Enrollment target
1
Study location

NCT04811014 is a Phase 4 study of Opioid Use Disorder and Opioid Use that is actively recruiting participants, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 250 participants, below the 4,655-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04811014, a Phase 4 study of Opioid Use Disorder and Opioid Use, is actively recruiting participants, sponsored by The University of Texas Health Science Center, Houston.

RECRUITING
Registry status
Phase 4
Development phase
250 participants
Enrollment target
1
Study location

Study Summary

The Houston Emergency Response Opioid Engagement System for Youths and Adolescents (Young HEROES) is a community-based research program integrating assertive outreach, medication for opioid use disorder (MOUD), behavioral counseling, and peer recovery support. The objective is to compare differences in engagement and retention in treatment for individuals with opioid use disorder. The investigators also intend to understand the prevalence of opioid overdoses and OUD among youth in Houston.

Conditions Studied

Opioid Use Disorder Opioid Use Substance Use Disorders Opioid Dependence Opioid Overdose

Interventions

  • DRUG Buprenorphine, Naloxone Drug Combination
  • BEHAVIORAL Individual Counseling
  • BEHAVIORAL Peer Recovery Support Services
  • BEHAVIORAL Support Group
  • BEHAVIORAL Referral to Medication Management

Study Locations (1)

Texas

  • The University of Texas Health Science Center at Houston - Houston

Trial Details

FieldValue
Enrollment Target 250 participants
Start Date 2021-04-19
Est. Completion 2030-08-31
Phase Phase 4

Sponsor

The University of Texas Health Science Center, Houston

732 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT04811014

The ClinicalTrials.gov registry entry for NCT04811014 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,655-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (95% lower). The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.

The record links to 5 conditions, with Opioid Use Disorder appearing as the primary indexed condition, and to 5 interventions - of which Buprenorphine, Naloxone Drug Combination is the first listed.

NCT04811014 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT04811014 about?

NCT04811014 is a clinical study titled "Young Houston Emergency Opioid Engagement System". The Houston Emergency Response Opioid Engagement System for Youths and Adolescents (Young HEROES) is a community-based research program integrating assertive outreach, medication for opioid use disorder (MOUD), behavioral counseling, and peer recovery support. The objective is to compare differences...

What is the current status of trial NCT04811014?

This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 250 participants. The study started on 2021-04-19. Estimated completion is 2030-08-31.

What conditions does trial NCT04811014 study?

This clinical trial studies the following conditions: Opioid Use Disorder, Opioid Use, Substance Use Disorders, Opioid Dependence, Opioid Overdose.

What interventions are being tested in trial NCT04811014?

The interventions under investigation include: Buprenorphine, Naloxone Drug Combination (DRUG), Individual Counseling (BEHAVIORAL), Peer Recovery Support Services (BEHAVIORAL), Support Group (BEHAVIORAL), Referral to Medication Management (BEHAVIORAL).

Who is sponsoring clinical trial NCT04811014?

This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04811014 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Opioid Use Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Opioid Use Disorder

All registered trials for this condition

Opioid Use

All registered trials for this condition

Texas

All trials with a study site in Texas

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.